| Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. | |
| | |
MedLine Citation:
|
PMID: 16488715 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Improved radiologic imaging provides earlier detection of non-small cell lung cancer, but controversy exists regarding the need for complete lymph node dissection. This study was designed to evaluate the possibility of lesser mediastinal dissection for early-stage lung cancer. METHODS: Selective mediastinal dissection is defined as follows: Dissection of the upper mediastinum for upper-lobe tumors is performed but it is not needed for lower-lobe tumors with intact hilar and lower mediastinal nodes. Also, dissection of the lower mediastinum for an upper-lobe tumor is not routinely required when the nodes in the hilum and upper mediastinum are negative. From 1997 through 2002, 377 patients with clinico-surgical stage I non-small cell lung cancer underwent curative-intent surgery with selective dissection (group S). In addition, 358 patients with the same-stage disease who underwent complete lymphadenectomy by the same surgical team served as historic controls (group C). RESULTS: The characteristics of the two groups were well balanced. There was no significant difference in disease-free survival (p = 0.376) or overall survival (p = 0.060). Multivariate analysis showed that the dissection mode did not significantly influence either disease-free survival (p = 0.636) or overall survival (p = 0.119). The postoperative morbidity rates were 17.3% and 10.1% for group C and group S, respectively (p = 0.005). One operative death occurred in each group (0.3%). The rates of distant metastasis and local recurrence were similar in the two groups. CONCLUSIONS: Selective mediastinal dissection for clinico-surgical stage I non-small cell lung cancer proved to be as effective as complete dissection, and although large multicenter trials are warranted, it might be considered as an alternative for curative surgery in this era of minimally invasive surgery. |
| | |
Authors:
|
Morihito Okada; Toshihiko Sakamoto; Tsuyoshi Yuki; Takeshi Mimura; Kei Miyoshi; Noriaki Tsubota |
Related Documents
:
|
7438015 - Prognostic significance of mediastinal involvement in hodgkin's disease treated with cu... 21741615 - Cumulative radiation dose from medical imaging procedures in patients undergoing resect... 18948305 - Worsened long-term outcomes and postoperative complications in octogenarians with lung ... 15170155 - Primary mediastinal large b-cell lymphoma: clinical study of a distinct clinical entity... 6585265 - Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. a clinicopatholog... 16574205 - Clinical impact of fdg-pet imaging in post-therapy surveillance of uterine cervical can... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Annals of thoracic surgery Volume: 81 ISSN: 1552-6259 ISO Abbreviation: Ann. Thorac. Surg. Publication Date: 2006 Mar |
Date Detail:
|
Created Date: 2006-02-20 Completed Date: 2006-09-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 15030100R Medline TA: Ann Thorac Surg Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 1028-32 Citation Subset: AIM; IM |
Affiliation:
|
Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan. morihito1217jp@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung / pathology, surgery* Disease-Free Survival Female Follow-Up Studies Humans Lung Neoplasms / pathology, surgery* Lymph Node Excision / methods* Lymphatic Metastasis Male Mediastinal Neoplasms / pathology*, surgery Neoplasm Staging Retrospective Studies Stents Time Factors Treatment Outcome |
| Comments/Corrections | |
Comment In:
|
Ann Thorac Surg. 2006 Mar;81(3):1033
[PMID:
16488716
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients.
Next Document: Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lu...